Table Of Content:
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Proteomics
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Proteomics Market By Component
1.2.2.1. Global Proteomics Market Revenue and Growth Rate Comparison By Component (2020-2027)
1.2.2.2. Global Proteomics Market Revenue Share By Component in 2019
1.2.2.2.1. Instruments
1.2.2.2.1.1. Microarray
1.2.2.2.1.2. Spectroscopy
1.2.2.2.1.3. X-ray Crystallography
1.2.2.2.1.4. Chromatography
1.2.2.2.1.5. Electrophoresis
1.2.2.2.1.6. Immunoassay
1.2.2.2.1.7. Protein Fractionation Reagents
1.2.2.2.2. Reagents
1.2.2.2.2.1. Microarray
1.2.2.2.2.2. Spectroscopy
1.2.2.2.2.3. X-ray Crystallography
1.2.2.2.2.4. Chromatography
1.2.2.2.2.5. Electrophoresis
1.2.2.2.2.6. Immunoassay
1.2.2.2.2.7. Protein Fractionation Reagents
1.2.2.2.3. Services
1.2.3. Proteomics Market By Application
1.2.3.1. Drug Discovery
1.2.3.2. Disease Diagnosis
1.2.3.3. Others
1.2.4. Proteomics Market By Geography
1.2.4.1. Global Proteomics Market Revenue and Growth Rate Comparison by Geography (2020-2027)
1.2.4.2. North America Proteomics Market Revenue and Growth Rate(2020-2027)
1.2.4.3. Europe Proteomics Market Revenue and Growth Rate(2020-2027)
1.2.4.4. Asia-Pacific Proteomics Market Revenue and Growth Rate(2020-2027)
1.2.4.5. Latin America Proteomics Market Revenue and Growth Rate(2020-2027)
1.2.4.6. Middle East and Africa (MEA) Proteomics Market Revenue and Growth Rate(2020-2027)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Pure Cashmere Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Pure Cashmere Major Manufacturers in 2019
3.3. R&D Status and Technology Source of Global Pure Cashmere Major Manufacturers in 2019
3.4. Raw Materials Sources Analysis of Global Pure Cashmere Major Manufacturers in 2019
CHAPTER 4. PROTEOMICS MARKET BY COMPONENT
4.1. Global Pure Cashmere Revenue By Component
4.2. Instruments
4.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.2.3. Microarray
4.2.4. Spectroscopy
4.2.5. X-ray Crystallography
4.2.6. Chromatography
4.2.7. Electrophoresis
4.2.8. Immunoassay
4.2.9. Protein Fractionation Reagents
4.3. Reagents
4.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.3.3. Microarray
4.3.4. Spectroscopy
4.3.5. X-ray Crystallography
4.3.6. Chromatography
4.3.7. Electrophoresis
4.3.8. Immunoassay
4.3.9. Protein Fractionation Reagents
4.4. Services
4.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
CHAPTER 5. PROTEOMICS MARKET BY APPLICATION
5.1. Global Pure Cashmere Revenue By Application
5.2. Drug Discovery
5.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.3. Disease Diagnosis
5.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
CHAPTER 6. NORTH AMERICA PROTEOMICS MARKET BY COUNTRY
6.1. North America Proteomics Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.2. North America Proteomics Market Revenue Share Comparison, 2020 & 2027 (%)
6.3. U.S.
6.3.1. U.S. Proteomics Market Revenue and Forecast By Component, 2020 - 2027 ($Million)
6.3.2. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Component, 2020 - 2027 ($Million)
6.4.2. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
CHAPTER 7. EUROPE PROTEOMICS MARKET BY COUNTRY
7.1. Europe Proteomics Market Revenue and Growth Rate, 2020 - 2027 ($Million)
7.2. Europe Proteomics Market Revenue Share Comparison, 2020 & 2027 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Component, 2020 - 2027 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Component, 2020 - 2027 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Component, 2020 - 2027 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Component, 2020 - 2027 ($Million)
7.6.2. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Component, 2020 - 2027 ($Million)
7.7.2. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
CHAPTER 8. ASIA-PACIFIC PROTEOMICS MARKET BY COUNTRY
8.1. Asia-Pacific Proteomics Market Revenue and Growth Rate, 2020 - 2027 ($Million)
8.2. Asia-Pacific Proteomics Market Revenue Share Comparison, 2020 & 2027 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Component, 2020 - 2027 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Component, 2020 - 2027 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Component, 2020 - 2027 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Component, 2020 - 2027 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Component, 2020 - 2027 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Component, 2020 - 2027 ($Million)
8.8.2. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
CHAPTER 9. LATIN AMERICA PROTEOMICS MARKET BY COUNTRY
9.1. Latin America Proteomics Market Revenue and Growth Rate, 2020 - 2027 ($Million)
9.2. Latin America Proteomics Market Revenue Share Comparison, 2020 & 2027 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Component, 2020 - 2027 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
9.4. Mexico
9.4.1. Market Revenue and Forecast By Component, 2020 - 2027 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Component, 2020 - 2027 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
CHAPTER 10. MIDDLE EAST & AFRICA PROTEOMICS MARKET BY COUNTRY
10.1. Middle East & Africa Proteomics Market Revenue and Growth Rate, 2020 - 2027 ($Million)
10.2. Middle East& Africa Proteomics Market Revenue Share Comparison, 2020 & 2027 (%)
10.3. GCC
10.3.1. Market Revenue and Forecast By Component, 2020 - 2027 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
10.4. South Africa
10.4.1. Market Revenue and Forecast By Component, 2020 - 2027 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
10.5. Rest of Middle East & Africa
10.5.1. Market Revenue and Forecast By Component, 2020 - 2027 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
CHAPTER 11. COMPANY PROFILE
11.1. Danaher Corporation
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Agilent Technologies Inc.
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. LI-COR, Inc.
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. PerkinElmer, Inc
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. HORIBA, Ltd.
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Bio-Rad Laboratories, Inc.
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. Thermo Fisher Scientific, Inc.
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Bruker Corporation
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. General Electric (GE)
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. Others
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
CHAPTER 12. RESEARCH APPROACH
12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope
Proteomics is a study of the protein structure and function used in drug development, diagnosis and disease management.
Structural proteomics are used to detect protein complex structures while functional proteomics are used to demonstrate protein functions in protein-protein interactions.
According to the Acumen Research and Consulting, The global proteomics market value is expected to reach around US$ 75,000 million by 2027.
The proteomics market is anticipated to grow around 14% CAGR amid the forecast period 2020-2027.
North America accounts to hold large market share of global proteomics market.
The key players operating in proteomics market such as Danaher Corporation, Agilent Technologies Inc., LI-COR, Inc., PerkinElmer, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Bruker Corporation, General Electric (GE), Waters Corporation, and others.
The presence of healthcare facilities are the major driving factors for the market in North America.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date